Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Oct 1996, 2609-2612, Vol 34, No. 10
AL Barry and PC Fuchs
Cefotaxime- and ceftriaxone-resistant Streptococcus pneumoniae is now
appearing in some medical centers, but 30-micrograms cefotaxime or 30-
micrograms ceftriaxone disks are not reliable for detecting such strains.
Studies were undertaken to select another cephalosporin disk that might be
used as a screening test that could be used in conjunction with a
1-micrograms oxacillin disk. A 30-micrograms cefuroxime disk is proposed:
strains with zones > or = 28 mm in diameter are predictably susceptible
to cefotaxime and ceftriaxone, and those with smaller zones should be
further studied to confirm resistance to either drug. A 30-micrograms
ceftizoxime disk may also be used as a screening test with zones > or =
26 mm indicating susceptibility, but cefuroxime disks are preferred.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae
Clinical Microbiology Institute, Tualatin, Oregon 97062, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»